During the past few years, many meta-analyses assessing the association between MTHFR gene polymorphism and cancer risks have been published, including liver cancer, ovary cancer, lung cancer, gastric cancer, pancreatic cancer, cervical cancer, and esophageal cancer [56–60]. The gene discussed is MTHFR; the disease is lung carcinoma.